Results 51 to 60 of about 1,633 (196)

Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases

open access: yesEBioMedicine, 2022
Summary: Background: Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) is a novel method to treat patients with peritoneal metastases (PM).
Wim Ceelen   +10 more
doaj   +1 more source

Anti‐Acanthamoeba Activities of Silica Nanoformulated Quercetin Compound Derived From Annona muricata L. Leaves

open access: yesScientifica, Volume 2026, Issue 1, 2026.
Acanthamoeba spp., free‐living amoebae (FLA), are the causative agents of Acanthamoeba keratitis (AK) and granulomatous amoebic encephalitis (GAE). These diseases have limited treatment options; therefore, drug discovery remains a critical priority. This study evaluated the leaf extract of Annona muricata L., which contains quercetin, formulated in ...
Hazel Anne Tabo   +20 more
wiley   +1 more source

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients [PDF]

open access: yes, 2020
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) represents a novel approach to intraperitoneal chemotherapy. Hereby results, obtained with PIPAC in patients with advanced peritoneal metastasis (PM) from colorectal cancer (CRC), are presented ...
Lundell, L,   +13 more
core   +1 more source

Peritoneal Immunosurgery: Immunotherapy Augmented Surgery for the Treatment of Peritoneal Cancers

open access: yesJournal of Surgical Oncology, Volume 132, Issue 5, Page 789-809, October 2025.
ABSTRACT Peritoneal malignancy often indicates disruptions in multiple physiological systems resulting from widespread cancer. The heterogenous origin and dynamic nature of peritoneal cancer make it difficult to treat with standard approaches that fit into guidelines.
Ada I. Ozcan   +4 more
wiley   +1 more source

Mean number of PIPAC procedures according to origin of PM.

open access: yes, 2023
Mean number of PIPAC procedures according to origin of PM.
Pierre-Louis Conan (17511346)   +7 more
core   +1 more source

Supporting decision making for individuals living with dementia and their care partners with knowledge translation: An umbrella review

open access: yesAlzheimer's &Dementia, Volume 21, Issue 9, September 2025.
Abstract Living with dementia requires decision making about numerous topics including daily activities and advance care planning (ACP). Both individuals living with dementia and care partners require informed support for decision making. We conducted an umbrella review to assess knowledge translation (KT) interventions supporting decision making for ...
Marie Biard   +10 more
wiley   +1 more source

HIPEC и PIPAC при раке желудка: методика и сравнение эффективности. Обзор литературы [PDF]

open access: yes, 2023
Background: According to the World Health Organization (WHO) data, gastric cancer (GC) was the 5th most common cancer and the 4th leading cause of cancer death worldwide in 2020.
Г. А. Раджабова   +9 more
core   +1 more source

Rapid Review of Interventions Designed to Enhance Personalised Care for People With Dementia When There Are Concerns About Reduced Awareness of Difficulties

open access: yesInternational Journal of Geriatric Psychiatry, Volume 40, Issue 9, September 2025.
ABSTRACT Objectives Awareness of difficulties varies in people with dementia. Low awareness, also termed anosognosia, has been implicated in carer stress and safety concerns, and can be a barrier to effective clinical communication. Little is known about how to manage situations arising from low awareness.
Catherine M. Alexander   +3 more
wiley   +1 more source

UEG Week 2021 Poster Presentations

open access: yes, 2021
United European Gastroenterology Journal, Volume 9, Issue S8, Page 262-907, October 2021.
wiley   +1 more source

Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines

open access: yesCancer Medicine, Volume 14, Issue 14, July 2025.
ABSTRACT Background Multimodality therapy incorporating a combination of cytoreductive surgery (CRS), intraperitoneal (IP) and systemic therapy continues to evolve for peritoneal carcinomatosis (PC) However, treatment and outcomes vary depending on tumor of origin.
Expert Panel Management of Peritoneal Carcinomatosis   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy